RESUMO
Objective:To investigate the clinical curative effect of Titanoreine suppositories combined with hypertonic magnesium sulfate solutions in the treatment of postpartum hemorrhoids acute attack. Methods:Totally 58 patients with postpartum hemorrhoids a-cute attack in our hospital from August 2012 to August 2013 were randomly divided into the observation group and the control group, 29 cases in each. The control group was treated with Titanoreine suppositories combined with hemorrhoids suppositories, and the observa-tion group was treated with Titanorein suppositories combined with hot compress using 50% sulfur acid magnesium liquids on the basis of sitz bath with potassium permanganate liquids. After the 7-day treatment, the clinical curative effect and adverse reactions were com-pared between the two groups. Results:The total effective rate in the observation group was 89. 7%(26/29), which was significantly higher than that in the control group 58. 6%(17/29). The pain relief rate on the first day was 93. 1% (27/29) in the observation group, which was also significantly higher than that in the control group 58. 6%(17/29) with statistically significant difference ( P<0. 01). Conclusion: Titanoreine suppositories combined with hypertonic magnesium sulfate solutions in the treatment of postpartum hemorrhoids acute attack is with rapid onset of action and obvious curative effect.
RESUMO
<p><b>OBJECTIVE</b>To assess the value of voiding urosonography (VUS) with SonoVue in evaluation of vesicoureteral reflux.</p><p><b>METHODS</b>Thirty-six pediatric patients (72 pyeloureter units [PUUs]) suspected of vesicoureteral reflux underwent both VUS and fluoroscopic voiding cystourethrography (VCUG). The sensitivity of VUS and VCUG and their consistency in detecting vesicoureteral reflux as well as in grading vesicoureteral reflux were compared.</p><p><b>RESULTS</b>Vesicoureteral reflux was detected in 26 of the 72 PUUs (36.1%) by VUS while in 21 PUUs (29.2%) by VCUG (P=0.347). The two modalities yielded the same results for 65 PUUs (κ=0.843), showing a very good consistency between them. VUS also detected post-urethral valve in 2 patients via transperineal scans.</p><p><b>CONCLUSION</b>VUS with Sonovue has at least comparable, if not better, sensitivity in detecting vesicoureteral reflux with VCUG, and therefore should serve as the primary screening and follow-up modality for vesicoureteral reflux. In addition, transperineal VUS can be helpful in evaluation of post-urethral lesions.</p>